DK0617620T3 - Anvendelse af 5-HT4-modulatorer til fremstilling af et lægemiddel til behandling af blærelidelser - Google Patents

Anvendelse af 5-HT4-modulatorer til fremstilling af et lægemiddel til behandling af blærelidelser

Info

Publication number
DK0617620T3
DK0617620T3 DK93900327T DK93900327T DK0617620T3 DK 0617620 T3 DK0617620 T3 DK 0617620T3 DK 93900327 T DK93900327 T DK 93900327T DK 93900327 T DK93900327 T DK 93900327T DK 0617620 T3 DK0617620 T3 DK 0617620T3
Authority
DK
Denmark
Prior art keywords
treatment
modulators
medicament
manufacture
bladder
Prior art date
Application number
DK93900327T
Other languages
English (en)
Inventor
Gareth John Sanger
Kay Alison Wardle
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919127185A external-priority patent/GB9127185D0/en
Priority claimed from GB919127184A external-priority patent/GB9127184D0/en
Priority claimed from GB929219354A external-priority patent/GB9219354D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK0617620T3 publication Critical patent/DK0617620T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DK93900327T 1991-12-21 1992-12-21 Anvendelse af 5-HT4-modulatorer til fremstilling af et lægemiddel til behandling af blærelidelser DK0617620T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919127185A GB9127185D0 (en) 1991-12-21 1991-12-21 Pharmaceuticals
GB919127184A GB9127184D0 (en) 1991-12-21 1991-12-21 Pharmaceuticals
GB929219354A GB9219354D0 (en) 1992-09-12 1992-09-12 Pharmaceuticals
PCT/GB1992/002376 WO1993012785A1 (en) 1991-12-21 1992-12-21 Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases

Publications (1)

Publication Number Publication Date
DK0617620T3 true DK0617620T3 (da) 1999-06-07

Family

ID=27265978

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93900327T DK0617620T3 (da) 1991-12-21 1992-12-21 Anvendelse af 5-HT4-modulatorer til fremstilling af et lægemiddel til behandling af blærelidelser

Country Status (9)

Country Link
EP (1) EP0617620B1 (da)
JP (1) JPH07502528A (da)
AT (1) ATE170747T1 (da)
AU (1) AU671430B2 (da)
CA (1) CA2126354C (da)
DE (1) DE69226961T2 (da)
DK (1) DK0617620T3 (da)
ES (1) ES2121984T3 (da)
WO (1) WO1993012785A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
WO1994008965A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
WO1996038420A1 (en) * 1995-05-31 1996-12-05 Nisshin Flour Milling Co., Ltd. Indazole derivatives having monocyclic amino group
KR20060067986A (ko) * 1998-06-15 2006-06-20 세프라코 아이엔시. 무호흡증, 대식증, 다른 질환을 치료하기 위한 광학적으로순수한 (+)-노르씨사프라이드의 용도
TR200003707T2 (tr) * 1998-06-15 2001-06-21 Sepracor Inc. Apne , bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
TWI263496B (en) * 1999-12-10 2006-10-11 Novartis Ag Pharmaceutical combinations and their use in treating gastrointestinal disorders
US20050261344A1 (en) * 2002-08-14 2005-11-24 Jones Charles R Treatment of lower urinary tract symptoms associated with overactive bladder in men and women

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2044854A1 (en) * 1990-07-19 1992-01-20 Hong-I Chen Method for preventing or treating urinary incontinence
GB9103862D0 (en) * 1991-02-25 1991-04-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
EP0617620A1 (en) 1994-10-05
WO1993012785A1 (en) 1993-07-08
JPH07502528A (ja) 1995-03-16
AU671430B2 (en) 1996-08-29
AU3168393A (en) 1993-07-28
DE69226961D1 (de) 1998-10-15
ATE170747T1 (de) 1998-09-15
EP0617620B1 (en) 1998-09-09
DE69226961T2 (de) 1999-04-29
CA2126354C (en) 2006-07-11
CA2126354A1 (en) 1993-07-08
ES2121984T3 (es) 1998-12-16

Similar Documents

Publication Publication Date Title
BR9206237A (pt) Uso de derivados de tetrahidrocarbazole como receptores agonistas 5-HT1.
MX9700030A (es) Administracion de pirenzipina, matilescopolamina y otros antagonistas del receptor mascurinico para el tratamiento de transtornos del metabolismo de lipidos.
EA199800340A1 (ru) Производные пиримидина как антагонисты 5нт2с
AP9801272A0 (en) Use of an antagonist of ppar-alpha and ppr-gamma for the treatment of syndrom X.
BRPI0007823A8 (pt) Métodos de supressão do glucagon
EA199900045A1 (ru) Производные спиропиперидина и их использование в качестве терапевтических агентов
DK0735868T3 (da) Anvendelse af ikke-steroide cyclooxygenaseinhibitorer til fremstilling af et medikament til behandling af forhøjet intrakul
DK1135153T3 (da) Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
DK0783893T3 (da) Inhibering af unormal vækst af synovial-celler under anvendelse af il-6-antagonist som aktiv bestanddel
MX9504687A (es) Silla con patas ajustables.
EA200200503A1 (ru) Способ лечения ревматоидного артрита
FR2773160B1 (fr) Resine de copolymere, sa preparation et photoresist utilisant celle-ci
EA199800857A1 (ru) Композиция для снятия боли и способ снятия боли
PT1319007E (pt) Compostos de succinimida heterociclicos fundidos e seus analogos enquanto moduladores da funcao dos receptores hormonais nucleares
DE69732868D1 (de) Mittel gegen Juckreiz
MX9204786A (es) Antagonistas del receptor 5-ht4 y composicion farmaceutica que los contiene.
DK1098649T3 (da) Fremgangsmåde til stabilisering af farmaceutiske sammensætninger med speciel anvendelse af antioxidant
ES2186783T3 (es) Derivados de la dolastatina, su preparacion y uso.
ES2121984T3 (es) Uso de antagonistas de 5-ht4 para la fabricacion de un medicamento para el tratamiento de la incontinencia urinaria.
DK0769293T3 (da) Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist
DK0696194T3 (da) Anvendelse af indolderivater som 5HT1-antagonister
EA199900450A1 (ru) Агент, индуцирующий апоптоз
EA200200303A1 (ru) Синергетические комбинации антагониста рецептора nk1 и структурного аналога гамк
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
DK0458590T3 (da) Behandling af okulær hypertension med en synergistisk konbination